Article
Six-month results show 88% achieving 20/40 for distance, 70% achieving J3 or better
Mercy Ships delivers a lifeline for eye health in Africa’s remote communities
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Study investigates neurological impact of diabetic vitreous hemorrhage
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Prevent Blindness names February as AMD and Low Vision Awareness Month
CHMP of the European Medicines Agency issues positive opinion on 2 aflibercept biosimilars